Compare API3 (API3) vs Injective (INJ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
API3 vs Injective — how do they compare? API3 trades at Rp3,958 (market cap Rp345,62M, Rp142,62M 24h volume), while Injective trades at Rp84,236 (market cap Rp8,47T, Rp1,4T 24h volume). The key difference: Injective is far larger — about 24506.7× API3's market cap, and API3's circulating supply is 86,4M API3 versus 100M INJ for Injective. Which is the better fit depends on your goals — on Pluang, investors hold API3 for 40 Days and Injective for 36 Days on average.
| API3 | INJ | |
|---|---|---|
Market Cap | Rp345,62M | Rp8,47T |
Volume (24h) | Rp142,62M | Rp1,4T |
Circulating Supply | 86,4M API3 | 100M INJ |
Typical Hold Time | 40 Days | 36 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
API3 is currently trading at Rp3,949 with a bearish technical signal, showing selling pressure across moving averages while oscillators remain neutral. The token faces immediate resistance at Rp4,104 and support at Rp3,942. With a market cap of Rp348.44 million and average hold time of 40 days, the asset shows moderate holding patterns amid current market conditions.
Overall outlook remains cautious with key resistance levels posing challenges for upward movement. Major risks include technical bearish momentum and limited liquidity, while opportunities exist if the token can break above resistance levels. Investors should monitor network adoption and exchange dynamics closely.
INJ is trading at Rp83,360 with a market cap of Rp8.39T, showing neutral technical signals overall. The asset is currently positioned between key support at Rp82,799 and resistance at Rp86,949, with mixed moving average signals but neutral oscillators. Recent network activity shows an average hold time of 36 days, indicating moderate holding behavior among investors.
Outlook remains cautiously neutral with potential for movement toward resistance levels. Key opportunities include protocol ecosystem growth, while risks involve typical crypto volatility and regulatory uncertainty. Investors should monitor volume patterns and network adoption metrics for directional cues.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About API3
API3 is an ERC-20 token based on the Ethereum blockchain. API3's goal is to allow decentralized versions of APIs to be built, managed, and monetized at scales. To achieve this in a fully decentralized way, the incentives of the participants are reconciled through the governance, security, and value capture utilities of the API3 token. The project has a completely open and direct governance model, where any API3 token holder can stake to obtain direct voting privileges in the API3 DAO.
Read more on API3 →About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →
